Robert J - Search Results

1

Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.

Guglielmetti L, Veziris N, Aubry A, Brossier F, Bernard C, Sougakoff W, Jarlier V, Robert J. Guglielmetti L, et al. Among authors: robert j. Int J Tuberc Lung Dis. 2018 Jan 1;22(1):54-59. doi: 10.5588/ijtld.17.0387. Int J Tuberc Lung Dis. 2018. PMID: 29297426

2

[The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].

Wyplosz B, Truffot-Pernot C, Robert J, Jarlier V, Grosset J. Wyplosz B, et al. Among authors: robert j. Rev Mal Respir. 1997 Dec;14 Suppl 5:S33-48. Rev Mal Respir. 1997. PMID: 9496590 Review. French.

3

Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.

Mouneimné H, Robert J, Jarlier V, Cambau E. Mouneimné H, et al. Among authors: robert j. Antimicrob Agents Chemother. 1999 Jan;43(1):62-6. doi: 10.1128/AAC.43.1.62. Antimicrob Agents Chemother. 1999. PMID: 9869566 Free PMC article.

4

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

Flament-Saillour M, Robert J, Jarlier V, Grosset J. Flament-Saillour M, et al. Among authors: robert j. Am J Respir Crit Care Med. 1999 Aug;160(2):587-93. doi: 10.1164/ajrccm.160.2.9901012. Am J Respir Crit Care Med. 1999. PMID: 10430733

5

A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.

Robert J, Boulahbal F, Trystram D, Truffot-Pernot C, de Benoist AC, Vincent V, Jarlier V, Grosset J. Robert J, et al. Int J Tuberc Lung Dis. 1999 Aug;3(8):711-4. Int J Tuberc Lung Dis. 1999. PMID: 10460104

6

Twenty-five years of tuberculosis in a French university hospital: a laboratory perspective.

Robert J, Trystram D, Truffot-Pernot C, Cambau E, Jarlier V, Grosset J. Robert J, et al. Int J Tuberc Lung Dis. 2000 Jun;4(6):504-12. Int J Tuberc Lung Dis. 2000. PMID: 10864180

7

Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group.

Robert J, Trystram D, Truffot-Pernot C, Carbonnelle B, Grosset J. Robert J, et al. Int J Tuberc Lung Dis. 2000 Jul;4(7):665-72. Int J Tuberc Lung Dis. 2000. PMID: 10907770

8

Activities of several antimicrobials against Mycobacterium ulcerans infection in mice.

Dega H, Robert J, Bonnafous P, Jarlier V, Grosset J. Dega H, et al. Among authors: robert j. Antimicrob Agents Chemother. 2000 Sep;44(9):2367-72. doi: 10.1128/AAC.44.9.2367-2372.2000. Antimicrob Agents Chemother. 2000. PMID: 10952581 Free PMC article.

9

Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.

Bentoucha A, Robert J, Dega H, Lounis N, Jarlier V, Grosset J. Bentoucha A, et al. Among authors: robert j. Antimicrob Agents Chemother. 2001 Nov;45(11):3109-12. doi: 10.1128/AAC.45.11.3109-3112.2001. Antimicrob Agents Chemother. 2001. PMID: 11600364 Free PMC article.

10

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98.

Robert J, Cambau E, Grenet K, Trystram D, Péan Y, Fiévet MH, Jarlier V. Robert J, et al. Clin Microbiol Infect. 2001 Oct;7(10):553-61. doi: 10.1046/j.1198-743x.2001.00322.x. Clin Microbiol Infect. 2001. PMID: 11683796 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,192 results

Search Page

Filters